HRMY vs. RGEN: Which Stock Is the Better Value Option?
ZACKS· 2025-01-31 01:41
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Harmony Biosciences Holdings, Inc. (HRMY) and Repligen (RGEN) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks ...
UEIC vs. GRMN: Which Stock Should Value Investors Buy Now?
ZACKS· 2025-01-31 01:41
Investors looking for stocks in the Electronics - Miscellaneous Products sector might want to consider either Universal Electronics (UEIC) or Garmin (GRMN) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank emphasizes companies with positive e ...
MDU or ATO: Which Is the Better Value Stock Right Now?
ZACKS· 2025-01-31 01:41
Investors with an interest in Utility - Gas Distribution stocks have likely encountered both MDU Resources (MDU) and Atmos Energy (ATO) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a proven strategy ...
EyePoint: A Risky 'Buy' Ahead Of Key Readout For Long-Acting Eylea Rival
Seeking Alpha· 2025-01-31 01:39
If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.The group is for both novice and experienced biotech investors. It provides catalysts to look out for and buy and sell ratings. It also provides product sales and forecasts ...
UPS shares drop as 2025 revenue guidance falls short
Proactiveinvestors NA· 2025-01-31 01:37
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
National Research's Q4 Earnings Drop Y/Y, Stock Falls 9%
ZACKS· 2025-01-31 01:36
Shares of National Research Corporation (NRC) have declined 9.1% since the company reported its earnings for the quarter ended Dec. 31, 2024. This compares to the S&P 500 index’s 0.6% decline over the same time frame. Over the past month, the stock has declined 7.4% compared with the S&P 500’s 0.4% growth.See the Zacks Earnings Calendar to stay ahead of market-making news.National Research reported earnings per share of 28 cents in the fourth quarter of 2024, down from 36 cents in the corresponding period l ...
Civista Bancshares: Mixed Performance Justifies Waiting
Seeking Alpha· 2025-01-31 01:34
The Pioneer Of Seeking Alpha's BAD BEAT Investing, Quad 7 Capital is a team of 7 analysts with a wide range of experience sharing investment opportunities for nearly 12 years. They are best known for their February 2020 call to sell everything & go short, & have been on average 95% long 5% short since May 2020. The broader company has expertise in business, policy, economics, mathematics, game theory, & the sciences. They share both long & short trades & invest personally in equities they discuss within the ...
Thermo Fisher Q4 Earnings and Revenues Top Estimates, Stock Up
ZACKS· 2025-01-31 01:31
Thermo Fisher Scientific Inc.'s (TMO) fourth-quarter 2024 adjusted earnings per share (EPS) of $6.10 beat the Zacks Consensus Estimate by 2.9%. The figure increased 7.6% year over year.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.The adjusted number excludes certain expenses, including asset amortization costs and certain restructuring costs.GAAP EPS was $4.78, up 13.8% on a year-over-year basis.Full-year adjusted EPS was $21.86, reflecting a 1.4% increase from the 2023 figure. The ...
Parker-Hannifin Q2 Earnings Beat, Aerospace Systems Sales Up Y/Y
ZACKS· 2025-01-31 01:31
Parker-Hannifin Corporation (PH) reported second-quarter fiscal 2025 (ended Dec. 31, 2024) adjusted earnings (excluding 72 cents from non-recurring items) of $6.53 per share, which beat the Zacks Consensus Estimate of $6.22. The bottom line jumped 6% year over year.Total sales of $4.74 billion missed the consensus estimate of $4.80 billion. The top line increased 1.6% year over year. Strength across businesses and transformed portfolio drove the top line. Organic sales grew 0.7% year over year. Orders grew ...
Polaris Slingshot Celebrates 10-Year Anniversary with Debut of 2025 Lineup, Delivering Fresh New Style
Prnewswire· 2025-01-31 01:30
Fully Redesigned Front End Adds Stand-Out Style Across 2025 Lineup; New Eight-Inch Speakers with Light Ring Enhances Audio and Adds Custom-Inspired StyleMINNEAPOLIS, Jan. 30, 2025 /PRNewswire/ -- Turning ordinary drives into extraordinary moments, the three-wheel Polaris Slingshot 2025 lineup combines one-of-a-kind, head-turning style with open-air, adventurous driving experiences unlike anything else on the road. New for 2025, Slingshot introduces a fully redesigned front end, all-new eight-inch speakers ...